Report #2896100

Received May 11, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: TN
Recovered: Recovered
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (2)

FatiguePyrexia

Symptom narrative

Fatigue; Fever; This non-serious case was reported by a nurse via sales rep and described the occurrence of fatigue in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced fatigue (Verbatim: Fatigue) and fever (Verbatim: Fever). The outcome of the fatigue and fever were resolved (duration 12 hrs). It was unknown if the reporter considered the fatigue and fever to be related to Shingrix. It was unknown if the company considered the fatigue and fever to be related to Shingrix. Additional Information: GSK receipt date 30-APR-2026 The patient was approximately 55 years took 2 dose series of shingrix. After one of doses patient experienced fatigue and fever.